FDA Warning Letter — Abryrx, Inc.

Case 144353 — FEI 3005972619

The FDA took a Warning Letter action against Abryrx, Inc. on January 6, 2011 (Irvington, NY). The action was issued by CDRH and concerns devices products. This facility has 2 recent FDA inspections on record.

Action Details

Facility
Abryrx, Inc.
Date
January 6, 2011
Fiscal Year
2011
Product Type
Devices
Center
CDRH
Location
Irvington, NY (United States)